SunTrust Banks Brokers Increase Earnings Estimates for American Renal Associates Holdings, Inc (ARA)

American Renal Associates Holdings, Inc (NYSE:ARA) – SunTrust Banks upped their FY2017 earnings per share estimates for shares of American Renal Associates Holdings in a report released on Wednesday. SunTrust Banks analyst D. Macdonald now expects that the company will post earnings per share of $0.58 for the year, up from their previous estimate of $0.57. SunTrust Banks also issued estimates for American Renal Associates Holdings’ Q4 2017 earnings at $0.20 EPS, Q2 2018 earnings at $0.18 EPS, Q3 2018 earnings at $0.19 EPS, Q4 2018 earnings at $0.22 EPS, FY2018 earnings at $0.72 EPS and FY2019 earnings at $0.84 EPS.

Several other analysts also recently commented on ARA. Zacks Investment Research raised American Renal Associates Holdings from a “sell” rating to a “hold” rating in a research note on Wednesday, May 10th. Wells Fargo & Company upgraded American Renal Associates Holdings from a “market perform” rating to an “outperform” rating in a research report on Thursday, May 11th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and five have issued a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average price target of $25.50.

WARNING: “SunTrust Banks Brokers Increase Earnings Estimates for American Renal Associates Holdings, Inc (ARA)” was reported by Stock Observer and is the sole property of of Stock Observer. If you are accessing this article on another website, it was illegally stolen and reposted in violation of US and international trademark and copyright laws. The original version of this article can be viewed at https://www.thestockobserver.com/2017/08/12/suntrust-banks-brokers-increase-earnings-estimates-for-american-renal-associates-holdings-inc-ara.html.

Shares of American Renal Associates Holdings (NYSE:ARA) opened at 14.44 on Thursday. American Renal Associates Holdings has a 12-month low of $13.74 and a 12-month high of $25.42. The firm’s market capitalization is $451.76 million. The company’s 50-day moving average price is $17.36 and its 200 day moving average price is $18.11.

American Renal Associates Holdings (NYSE:ARA) last posted its earnings results on Tuesday, August 8th. The company reported $0.16 EPS for the quarter, topping the consensus estimate of $0.12 by $0.04. The firm had revenue of $185.99 million for the quarter, compared to analyst estimates of $188.23 million. American Renal Associates Holdings had a positive return on equity of 18.25% and a negative net margin of 1.54%. The firm’s revenue for the quarter was up .2% on a year-over-year basis.

A number of institutional investors have recently added to or reduced their stakes in the company. State Street Corp boosted its position in American Renal Associates Holdings by 6.0% in the fourth quarter. State Street Corp now owns 172,589 shares of the company’s stock valued at $3,673,000 after buying an additional 9,745 shares during the last quarter. Teachers Advisors LLC boosted its position in American Renal Associates Holdings by 42.6% in the fourth quarter. Teachers Advisors LLC now owns 20,092 shares of the company’s stock valued at $428,000 after buying an additional 6,000 shares during the last quarter. AMI Asset Management Corp boosted its position in American Renal Associates Holdings by 17.8% in the first quarter. AMI Asset Management Corp now owns 447,331 shares of the company’s stock valued at $7,551,000 after buying an additional 67,725 shares during the last quarter. Atria Investments LLC acquired a new position in American Renal Associates Holdings during the first quarter valued at about $181,000. Finally, Acadian Asset Management LLC acquired a new position in American Renal Associates Holdings during the first quarter valued at about $588,000. Institutional investors own 90.93% of the company’s stock.

About American Renal Associates Holdings

American Renal Associates Holdings, Inc is a dialysis service provider in the United States focused on joint venture (JV) partnerships with physicians. As of December 31, 2016, the Company owned and operated 214 dialysis clinics in partnership with 379 nephrologist partners treating over 14,000 patients in 25 states and the District of Columbia.

Earnings History and Estimates for American Renal Associates Holdings (NYSE:ARA)

Receive News & Ratings for American Renal Associates Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Renal Associates Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply